Kuros Biosciences AG (LON:0RHR)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	989	710	120	48	51	55
Market Cap Growth	927.77%	493.74%	148.06%	-5.72%	-6.74%	27.87%
Enterprise Value	974	699	107	31	31	44
Last Close Price	25.78	18.92	3.25	1.35	1.62	1.71
PS Ratio	14.85	10.66	3.82	2.99	4.57	16.40
PB Ratio	19.10	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	46.14	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	548.82	393.96	-	-	-	-
P/OCF Ratio	357.43	256.57	-	-	-	-
EV/Sales Ratio	13.94	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	-	385.86	-	-	-	-
EV/EBIT Ratio	-	7414.24	-	-	-	-
EV/FCF Ratio	540.49	387.93	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-
Debt / FCF Ratio	0.88	0.88	-	-	-	-
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	-0.38%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	0.18%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.